"CSC Pharma", UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 2,209,005 |
| 226,101 |
| 14,731 |
| 6,044 |
| 619 |
| 28.78 |
| 0.27 |
| 31,809 |
| 514,496 |
| 5,041 |
| 545,609 |
| 2023 |
|---|
| 2,393,920 |
| 226,482 |
| 25,378 |
| 13,459 |
| 1,273 |
| 27.44 |
| 0.56 |
| 45,267 |
| 531,414 |
| 5,701 |
| 580,258 |
| 2024 |
|---|
| 2,371,791 |
| 221,249 |
| 16,918 |
| 8,576 |
| 800 |
| 22.29 |
| 0.36 |
| 53,843 |
| 503,355 |
| 3,406 |
| 549,293 |
Register and
explore Okredo data| 2024 |
|---|
| 2,371,791 |
| 221,249 |
| 16,918 |
| 8,576 |
| 800 |
| 22.29 |
| 0.36 |
| 53,843 |
| 503,355 |
| 3,406 |
| 549,293 |
Register and
explore Okredo data2024
Turnover (€)
2,371,791 €
-1 % *
Sales per employee (€)
221,249 €-2 % *
Profit before tax (€)
16,918 €-33 % *
Net Profit (€)
8,576 €-36 % *
Profit per employee (€)
800 €-37 % *
Total profitability (%)
22.29 %-18.77 % *
Net profitability (%)
0.36 %-35.71 % *
Equity (€)
53,843 €
19 % *
Amounts Payable And Liabilities (€)
503,355 €
-5 % *
Non-current Assets (€)
3,406 €-40 % *
CurrentAssets (€)
549,293 €-5 % *